Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
Antibodies to glutamic acid decarboxylase (GAD), the major pathway for the synthesis of c-aminobutyric acid(GABA) in humans, are found at elevated levels in a subgroup of patients with chronic epilepsy. To test whether the antibodies were associated with changes in cortical GABA levels we used magne...
Main Authors: | Stagg, C, Lang, B, Best, J, McKnight, K, Cavey, A, Johansen-Berg, H, Vincent, A, Palace, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
SERUM AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE ARE ASSOCIATED WITH REDUCED CORTICAL GABA LEVELS IN PATIENTS WITH EPILEPSY
by: Stagg, C, et al.
Published: (2009) -
The role of anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) in idiopathic late onset cerebellar ataxia (ILOCA)
by: Muzaimi, M, et al.
Published: (2004) -
Glutamic Acid Decarboxylase Autoantibodies-Related Encephalitis
by: J Gordon Millichap
Published: (2011-09-01) -
Autoantibodies as a cause of epilepsy
by: Wroe, S, et al.
Published: (2003) -
Serum antibodies in patients with epilepsy
by: Lang, B, et al.
Published: (2005)